3,289 followers
Ruxolitinib, inhibitor of JAK-STAT signalling, inhibited osteoblastic differentiation and matrix mineralization of hMSCs in vitro and reduced ectopic bone formation in vivo. Nihal AlMuraikhi et al. Stem Cell Research & Therapy 2018 9:319 https://t.co/k